Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT06945393
Brief Summary:
The study intends to validate a protocol and define a positive reference to evaluate the efficacy of anti-pigmenting and depigmenting agents under part of visible Light exposures, between 400nm to 450nm.
It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Detailed Description:
The main objective of this study is to assess the efficacy of antipigmenting or depigmenting agents under \[400-450nm\] exposure in healthy volunteers by skin colorimetry (Delta E).
The secondary objectives are:
* To assess the efficacy of antipigmenting or depigmenting agents under \[400-450nm\] exposure in healthy volunteers by clinical evaluation and additional colorimetry measurements (Delta L\*, a\*, b\* and ITA°) and clinical evaluation.
* To assess the local tolerance and safety of the topical formulations under \[400-450nm\] exposure by recording adverse events and safety.
Study:
NCT06945393
Study Brief:
Protocol Section:
NCT06945393